Independent Franchise Partners Reduces Johnson & Johnson Holdings

Investment firm cuts stake in pharmaceutical giant by 12.5% in Q3

Mar. 14, 2026 at 8:37am

Got story updates? Submit your updates here. ›

Independent Franchise Partners LLP, a major investment firm, reduced its holdings in Johnson & Johnson (NYSE: JNJ) by 12.5% during the third quarter of 2026. The firm now owns 4,588,890 shares of the company's stock, valued at approximately $850.87 million, making it one of Johnson & Johnson's largest institutional investors.

Why it matters

Johnson & Johnson is a bellwether stock in the healthcare and pharmaceutical sectors, so changes in major institutional holdings can signal broader market trends and investor sentiment around the company and its prospects.

The details

According to a recent SEC filing, Independent Franchise Partners sold 655,248 shares of Johnson & Johnson stock during the third quarter. The firm now owns approximately 0.19% of Johnson & Johnson's outstanding shares. Johnson & Johnson remains one of Independent Franchise Partners' top five holdings, comprising around 5.6% of the firm's total portfolio.

  • Independent Franchise Partners filed its 13F report for the third quarter of 2026 on March 14, 2026.

The players

Independent Franchise Partners LLP

An investment management firm based in the United Kingdom that focuses on long-term, fundamental investing.

Johnson & Johnson

A multinational pharmaceutical and medical devices company headquartered in New Brunswick, New Jersey.

Got photos? Submit your photos here. ›

The takeaway

The reduction in Independent Franchise Partners' Johnson & Johnson holdings, while relatively small, could signal a broader shift in investor sentiment around the healthcare giant as it navigates challenges like patent expirations and pricing pressures. However, the stock remains a core holding for the firm, underscoring Johnson & Johnson's enduring appeal as a defensive, blue-chip investment.